Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

NCT07155707 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT07155707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07155707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Recruiting
Start date
June 24, 2026
Completion date
September 15, 2027
Enrollment
156 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, mood disorders